Related Experiment Video
Updated: Jul 17, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Developing an HPV vaccine to prevent cervical cancer and genital warts
1Vaccine and Biologics Research, Merck Research Laboratories, Merck & Co., Inc., West Point, PA, United States. janine_bryan@merck.com
Abstract:
The challenges of the journey from target identification through development of a prophylactic quadrivalent human papillomavirus (HPV) vaccine have been met in Gardasil. Cervical cancer is the second leading cause of cancer-related death in women worldwide. Approximately 70% of cervical cancer is caused by infection with HPV types 16 and 18 and approximately 90% of genital warts are caused by HPV types 6 and 11. The quadrivalent HPV vaccine was generated by expression of the major capsid protein (L1) of HPV types 16, 18, 6 and 11 in yeast. L1 proteins self assemble into pentamer structures and these pentamer structures come together to form virus-like particles (VLPs). The VLPs are antigenically indistinguishable from HPV virions. The VLPs contain no viral DNA and therefore the vaccine is non-infectious. Gardasil is composed of VLPs of HPV types 16, 18, 6 and 11 conjugated to a proprietary amorphous aluminum hydroxyphosphate sulfate adjuvant. The results of a rigorous clinical program have demonstrated that the vaccine is safe and highly efficacious in preventing dysplasias, cervical intraepithelial neoplasias (CIN 1-3) the precursors of cervical cancer and external genital lesions caused by vaccine-HPV types. In conclusion, Gardasil addresses a major medical need, that is, reduction of HPV-related disease including cervical cancer as a safe, immunogenic, and highly efficacious vaccine.
Insights
Gardasil is a safe and effective quadrivalent human papillomavirus (HPV) vaccine that prevents HPV-related diseases, including cervical cancer and genital warts. This prophylactic vaccine targets HPV types 6, 11, 16, and 18.
Area of Science:
- Vaccinology
- Oncology
- Virology
Background:
- Cervical cancer is a significant global health concern, ranking as the second leading cause of cancer-related deaths in women.
- Infections with specific human papillomavirus (HPV) types, particularly HPV 16 and 18, are responsible for approximately 70% of cervical cancers.
- Genital warts are predominantly caused by HPV types 6 and 11, accounting for about 90% of cases.
Purpose of the Study:
- To evaluate the safety and efficacy of a prophylactic quadrivalent HPV vaccine, Gardasil.
- To demonstrate the vaccine's ability to prevent HPV-related diseases, including cervical cancer precursors and genital lesions.
Main Methods:
- The quadrivalent HPV vaccine was developed using yeast expression of the L1 major capsid protein from HPV types 6, 11, 16, and 18.
- L1 proteins self-assembled into virus-like particles (VLPs), which are antigenically equivalent to native HPV virions but contain no viral DNA, ensuring non-infectivity.
- Gardasil comprises these VLPs conjugated to an amorphous aluminum hydroxyphosphate sulfate adjuvant.
Main Results:
- Clinical trials demonstrated that Gardasil is safe and highly effective.
- The vaccine successfully prevented cervical intraepithelial neoplasias (CIN 1-3), which are precancerous lesions of the cervix.
- Efficacy was also shown in preventing external genital lesions caused by the vaccine HPV types.
Conclusions:
- Gardasil effectively addresses the medical need for reducing HPV-related diseases, including cervical cancer.
- The vaccine is a safe, immunogenic, and highly efficacious option for prophylaxis against HPV infection.
- The development of Gardasil represents a significant advancement in preventing HPV-related morbidities.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Genital Herpes
Chickenpox
Vaccinations
Smallpox
Sexually Transmitted Infections